Persistent edematous-plaque photosensitivity observed with sitagliptin phosphate (Januvia®)

Dermatology Online Journal

Volumn 18, Issue 2, 2012, Pages

  Stricklin, Sherea M ^a   Stoecker, William V ^a   Rader, Ryan K ^a   Hood, Antoinette F ^b   Litt, Jerome Z ^c   Schuman, Thomas P ^d  

^a Eastern Virginia Medical School Department of Dermatology ^*

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MISSOURI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL ANTIDIABETIC AGENT; SITAGLIPTIN; SUNSCREEN; ANTIDIABETIC AGENT; DIPEPTIDYL PEPTIDASE IV INHIBITOR; PYRAZINE DERIVATIVE; TRIAZOLE DERIVATIVE;

AGED; ARTICLE; CASE REPORT; DIABETES MELLITUS; DISEASE SEVERITY; DRUG WITHDRAWAL; EOSINOPHIL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PARAKERATOSIS; PERSISTENT EDEMATOUS PLAQUE PHOTOSENSITIVITY; PHOTOSENSITIVITY; PHYSICAL EXAMINATION; PROTECTIVE CLOTHING; PRURITUS; SKIN BIOPSY; SKIN PROTECTION; SUN EXPOSURE; ULTRAVIOLET SPECTROPHOTOMETRY; CHEMICALLY INDUCED DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PHOTOSENSITIVITY DISORDER; TREATMENT OUTCOME;

AGED; DIABETES MELLITUS, TYPE 2; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; HUMANS; HYPOGLYCEMIC AGENTS; MALE; PHOTOSENSITIVITY DISORDERS; PROTECTIVE CLOTHING; PYRAZINES; TREATMENT OUTCOME; TRIAZOLES;

EID: 84857808958     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. British Photodermatology Group. Photopatch testing--methods and indications. Br J Dermatol. 1997 Mar;136(3):371-6.
2. Pathade, P., Imran, Md., Bairagi, V., Ahire, Y., Development and Validation of Stability Indicating UV Spectrophotometric Method for the Estimation of Sitagliptin Phosphate in Bulk and Tablet Dosage Form, Journal of Pharmacy Research. 2011;4(3):871-873.
3. Farmer KC, Naylor MF. Sun exposure, sunscreens, and skin cancer prevention: a year-round concern. Ann Pharmacother. 1996 Jun;30(6):662-73.
4. Palalau AI, Tahrani AA, Piya MK, Barnett AH. DPP-4 inhibitors in clinical practice. Postgrad Med. 2009;121(6):70-100.
5. Kastalli S, El Aïdli S, Chaabane A, Amrani R, Daghfous R, Belkahia C. [Photosensitivity induced by metformin: a report of 3 cases]. Tunis Med. 2009;87(10):703-5.
6. Sun CC. Photosensitivity due to glyburide. Photodermatol. 1988;5(1):42-5.
7. Litt JZ. Drug Eruptions and Reactions Manual. 16th Edition. London, Informa. 2010
8. "Photosensitivity Reaction in Januvia, Reported by 8 People-EHealthMe. com. " EHealthMe-Real World Drug Outcomes. http://www.ehealthme.com/ds/januvia/photosensitivity+reaction, accessed December 20, 2011.
9. Que SK, Brauer JA, Soter NA, Cohen DE. Chronic actinic dermatitis: an analysis at a single institution over 25 years. Dermatitis. 2011 Jun;22(3):147-54.
10. Somani VK. Chronic actinic dermatitis-a study of clinical features. Indian J Dermatol Venereol Leprol 2005;71:409.
11. Chew AL, Bashir SJ, Hawk JL, Palmer R, White IR, McFadden JP. Contact and photocontact sensitization in chronic actinic dermatitis: a changing picture. Contact Dermatitis. 2010 Jan;62(1):42-6.
12. Hawk JLM, Magnus IA. Chronic actinic dermatitis-an idiopathic photosensitivity syndrome including actinic reticuloid and photosensitive eczema. Br J Dermatol 1979;101(Suppl 17):24.
13. Booth AV, Mengden S, Soter NA, Cohen D. Chronic actinic dermatitis. Dermatol Online J 2008 May 15;14(5):25.
14. Hawk JLM. Chronic actinic dermatitis. Photodermatol Photoimmunol Photomed 2004;20:312.
15. Kochevar IE, Harber LC. Photoreactions of 3, 3', 4', 5-tetrachlorosalicylanilide with proteins. J Invest Dermatol 1977;68:151.